Abstract
OBJECTIVE: To assess the efficacy of desmopressin and imipramine in reducing urination frequency, and retaining the instilled suspension in the bladder without maintaining the mouse under anesthesia.
METHOD: Twenty-four mice were divided into four groups: (1) control, (2) four-hour water deprivation, (3) two µg/kg intraperitoneal desmopressin, and (4) two µg/kg intraperitoneal desmopressin plus 30 mg/kg imipramine gavage. Micturition frequency was recorded using voiding spot assay. Animals were catheterized and 50 µl of methylene blue was instilled into the bladder. The mice were then placed on a white paper to recover. Blue voiding was documented.
RESULTS: Urination frequency was significantly lower in the desmopressin group. The water-deprived and desmopressin/imipramine-combination groups did not differ significantly compared to control group. All animals voided methylene blue upon recovery.
CONCLUSION: Desmopressin notably reduced urination frequency. In contrast, water deprivation did not do so. Desmopressin and imipramine failed to cause suspension retention in awake mice.
Reference10 articles.
1. Fry C, Daneshgari F, Thor K, Drake M, Eccles R, Kanai A, et al. Animal models and their use in understanding lower urinary tract dysfunction. 2010;29(4):603-8.
2. Chan E, Patel A, Heston W, Larchian WJBi. Mouse orthotopic models for bladder cancer research. 2009;104(9):1286-91.
3. Bitaraf M, Muhammadnejad S, Azimzadeh A, Tanourlouee SB, Amini E, Zolbin MM, et al. Evaluation of direct intramural injection to the bladder wall as a method for developing orthotopic tumor models.n/a (n/a).
4. Hiles GL, Cates AL, El-Sawy L, Day KC, Broses LJ, Han AL, et al. A surgical orthotopic approach for studying the invasive progression of human bladder cancer. 2019;14(3):738-55.
5. Seager CM, Puzio-Kuter AM, Patel T, Jain S, Cordon-Cardo C, Mc Kiernan J, et al. Intravesical delivery of rapamycin suppresses tumorigenesis in a mouse model of progressive bladder cancer. 2009;2(12):1008-14.